Study Shows Dramatic Increase of Unintentional Therapeutic Errors Involving Insulin

Results from a data analysis show an increasing trend of unintentional therapeutic errors involving insulin in the ambulatory setting, according to a study published in the Annals of Pharmacotherapy.

Advertisement

Researchers conducted a search of all medical records involving insulin at nine poison centers from 2000-2009. During this time period, there were 3,819 reported insulin exposures with a mean annual increase of 18 percent. Of the total number of insulin exposure, researchers concluded 2,584 cases (68 percent) were unintentional therapeutic errors. Every year, there was a progressive increase in the number of unintentional therapeutic errors involving insulin, with a mean annual increase of 28 percent.

Results also showed a high incidence of unintentional therapeutic errors involving insulin in the late evening hours, in adults aged 40 years or older and females.

Read the study about unintentional therapeutic errors involving insulin.

Read other coverage about patient safety:

H&P Issues Voluntary Recall of Povidine Iodine Prep Pads Due to Microbial Infection

Using Color to Differentiate Drug Strength Can Improve Medication Safety

Washington Bill Would Give More Rights to Individuals Claiming Medical Errors

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in ASC Accreditation, Licensure & Medicare Certification

Advertisement

Comments are closed.